Shah Preetam
SEC insider (Form 3/4/5 filer). CIK 0001787403. Officer at Elicio Therapeutics, Inc. (ELTX) and 1 other issuer. 4 reported Form 4/5 transactions since Sep 2024; latest on Jul 16, 2026. Located in BOSTON, MA.
Companies Shah Preetam has filed insider reports for
- Elicio Therapeutics, Inc. (ELTX): Officer, See Remarks
- Cidara Therapeutics, Inc. (CDTX): Officer, Chief Financial Officer
Shah Preetam
CIK: 0001787403
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jul 16, 2026ELTX
Elicio Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
60.8K shares- - Feb 2, 2026ELTX
Elicio Therapeutics, Inc.
AwardDirect24K shares- - Apr 15, 2025ELTX
Elicio Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
191.6K shares- - Sep 30, 2024CDTX
Cidara Therapeutics, Inc.
AwardDirectEmployee Stock Option (right to buy)
130.1K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 16, 2026 |  ELTX Elicio Therapeutics, Inc. | Award Stock Option (Right to Buy) | 60,833 | - | - | Direct |
| Feb 2, 2026 | ELTX Elicio Therapeutics, Inc. | Award | 24,000 | - | $0 | Direct |
| Apr 15, 2025 | ELTX Elicio Therapeutics, Inc. | Award Stock Option (Right to Buy) | 191,624 | - | - | Direct |
| Sep 30, 2024 |  CDTX Cidara Therapeutics, Inc. | Award Employee Stock Option (right to buy) | 130,087 | - | - | Direct |
1-4 of 4 transactions